Subclinical hypothyroidism guidelines ‘not supported by evidence’, critics say

A spat has erupted over new practice guidelines that advise against prescribing thyroid hormone replacement therapy for adults with subclinical hypothyroidism.
The British Thyroid Association and the Society for Endocrinology in the UK have criticised the recommendations, published in the BMJ last month, citing concerns patients may miss out on crucial early treatment and therefore progress to hypothyroidism.